Structures by: Packianathan T. M.
Total: 52
Tetra(2-amino-4,6-dimethylpyrimidinium) bis(sulfosalicylate) dihydrate
2(C6H10N3),C7H4O6S,H2O
Chemistry Central Journal (2007) 1, 28
a=9.2466(2)Å b=14.0976(3)Å c=17.6365(4)Å
α=94.0280(10)° β=101.1930(10)° γ=91.9680(10)°
Pyrimethamine benzene sulfonate monohydrate
C72H76Cl4N16O14S4
Chemistry Central Journal (2007) 1, 28
a=10.2783(3)Å b=13.6919(3)Å c=15.4164(4)Å
α=102.863(2)° β=102.187(2)° γ=108.805(2)°
2-amino-4,6-dimethoxypyrimidine--4-aminobenzoic acid (1/1)
C6H9N3O2,C7H7NO2
Acta Crystallographica Section E (2006) 62, 7 o2976-o2978
a=6.6358(4)Å b=7.5560(5)Å c=27.4226(16)Å
α=90° β=94.418(2)° γ=90°
Trimethoprim hydrogenmalonate
C14H19N4O3,C3H3O4
Acta Crystallographica Section E (2004) 60, 12 o2350-o2352
a=8.4851(2)Å b=8.6566(2)Å c=13.6425(3)Å
α=106.360(3)° β=91.712(2)° γ=92.950(3)°
Pyrimethaminium sulfosalicylate monohydrate
C12H14ClN4,C7H5O6S,H2O
Acta Crystallographica Section E (2005) 61, 5 o1480-o1482
a=15.2350(15)Å b=19.3290(12)Å c=15.8750(14)Å
α=90° β=113.960(6)° γ=90°
Trimethoprim trifluoroacetate
C14H19N4O31,C2F3O21
Acta Crystallographica Section E (2002) 58, 7 o717-o719
a=10.380(2)Å b=19.091(3)Å c=9.947(2)Å
α=90° β=112.17(2)° γ=90°
Sodium complex of HQS
C9H6NNaO4S
Acta Crystallographica Section E (2002) 58, 10 m513-m516
a=8.284(2)Å b=10.488(2)Å c=10.916(2)Å
α=90° β=103.25(2)° γ=90°
Nickel-ferron complex
C18H20I2N2Ni2O14S2,4H2O
Acta Crystallographica Section E (2003) 59, 1 m46-m49
a=22.053(4)Å b=10.009(2)Å c=13.241(3)Å
α=90° β=100.760(3)° γ=90°
Trimethoprim terephthalate terephthalic acid
2C14H19N4O3,C8H4O42,C8H6O4
Acta Crystallographica Section E (2003) 59, 1 o14-o17
a=8.438(2)Å b=10.760(3)Å c=12.538(3)Å
α=90.26(3)° β=98.22(2)° γ=109.54(3)°
Magnesium ferron pentahydrate
C18H20I2Mg2N2O14S2,4H2O
Acta Crystallographica Section E (2004) 60, 2 m137-m139
a=22.584(5)Å b=10.026(2)Å c=13.401(3)Å
α=90° β=102.26(3)° γ=90°
4,4'-bipyridinium sulfosalicyclate monohydrate
C10H10N22,2C7H5O6S1,2H2O
Acta Crystallographica Section E (2003) 59, 12 o2015-o2017
a=7.086(2)Å b=16.669(3)Å c=10.915(3)Å
α=90° β=98.13(3)° γ=90°
(2-amino-4,6-dimethylpyrimidine)(nickel(II)thiocyante)
C2H8N2NiO4S2,4C6H9N3,2H2O
Acta Crystallographica Section E (2005) 61, 2 m204-m206
a=7.8006(5)Å b=11.6289(8)Å c=11.9121(8)Å
α=67.7010(10)° β=75.4880(10)° γ=78.8960(10)°
Bis(4,4'-bipyridinium) bis(8-hydroxyquinoline-5-sulfonate) bipyridine pentahydrate
2C10H9N21,2C9H6SO41,C10H8N2,5H2O
Acta Crystallographica Section E (2003) 59, 12 o1980-o1983
a=9.449(3)Å b=14.330(2)Å c=19.449(3)Å
α=111.080(2)° β=93.730(3)° γ=104.770(2)°
Potassium HQS monohydrate
C9H8KNO5S
Acta Crystallographica Section E (2003) 59, 12 m1154-m1156
a=9.885(2)Å b=10.083(2)Å c=11.269(3)Å
α=90° β=101.14(2)° γ=90°
Copper ferron hexahydrate
C9H8CuINO6S,4H2O
Acta Crystallographica Section E (2003) 59, 12 m1157-m1159
a=7.321(2)Å b=9.682(3)Å c=22.817(3)Å
α=90° β=96.54(2)° γ=90°
Calcium ferron trihydrate
C18H14CaI2N2O10S2,H2O
Acta Crystallographica Section E (2003) 59, 12 m1160-m1163
a=20.326(4)Å b=6.9580(10)Å c=19.219(4)Å
α=90° β=117.19(3)° γ=90°
Trimethoprim fluoroborate
C14H19N4O3,BF4
Acta Crystallographica Section E (2005) 61, 12 o4107-o4109
a=9.4105(3)Å b=9.5397(2)Å c=10.1276(4)Å
α=88.564(2)° β=73.253(2)° γ=72.304(2)°
Kynathrin cinnamic acid
C6H9N3,2C9H8O2
Acta Crystallographica, Section E (2005) 61, 1 o4203-o4205
a=32.045(2)Å b=8.7676(7)Å c=15.9796(10)Å
α=90° β=90° γ=90°
Kynathrin 4-hydroxy benzoic acid
C6H9N3,C7H6O3
Acta Crystallographica Section E (2006) 62, 7 o2907-o2909
a=9.0693(3)Å b=11.1141(4)Å c=12.6080(5)Å
α=90° β=102.916(2)° γ=90°
Trimethoprim dipicolinate pentahydrate
2C14H19N4O3,C7H3NO42,5H2O
Acta Crystallographica Section E (2005) 61, 8 o2368-o2371
a=9.713(2)Å b=12.025(3)Å c=35.703(3)Å
α=90° β=94.23(3)° γ=90°
Diaminopyrimidinium sulfate monohydrate
2C4H7N4O,O4S2,H2O
Acta Crystallographica Section E (2004) 60, 11 o2038-o2040
a=15.014(3)Å b=6.568(2)Å c=15.330(3)Å
α=90° β=106.69(2)° γ=90°
Zinc ferron pentahydrate
C18H20I2N2O14S2Zn2,4(H2O)
Acta Crystallographica Section E (2003) 59, 2 m87-m90
a=22.278(4)Å b=10.076(3)Å c=13.496(2)Å
α=90° β=102.29(3)° γ=90°
O-Vanillin chlorophenyl imine
C14H12ClNO2
Acta Crystallographica Section E (2003) 59, 7 o1045-o1047
a=6.4090(10)Å b=13.0620(10)Å c=14.8420(10)Å
α=90° β=90° γ=90°
Barium ferron tetrahydrate
C9H10BaINO7S,H2O
Acta Crystallographica Section E (2003) 59, 12 m1164-m1167
a=7.600(3)Å b=10.089(2)Å c=10.261(3)Å
α=89.60(3)° β=77.52(2)° γ=85.63(3)°
Cadmium ferron tetrahydrate
C9H8CdINO6S,2H2O
Acta Crystallographica Section E (2004) 60, 1 m62-m64
a=6.9220(8)Å b=10.1310(12)Å c=10.9630(13)Å
α=76.013(2)° β=74.869(2)° γ=85.318(2)°
(2-amino-4,6-dimethylpyrimidine)(cadmium(II)thiocyante)
C2H4CdN2O2S2,2(C6H9N3)
Acta Crystallographica Section E (2005) 61, 1 m63-m65
a=5.7221(4)Å b=10.3906(8)Å c=10.4865(8)Å
α=117.4420(10)° β=101.6770(8)° γ=92.9510(10)°
2-amino-4,6-dimethylpyrimidinium picrate
C6H10N3,C6H2N3O7
Acta Crystallographica Section E (2006) 62, 9 o3847-o3849
a=9.646(3)Å b=10.990(3)Å c=8.351(3)Å
α=79.86(3)° β=67.75(3)° γ=66.62(3)°
Pyrimethamine hydrogen adipate
C12H14ClN4,C6H9O4
Acta Crystallographica Section E (2007) 63, 10 o4065-o4066
a=8.1540(10)Å b=11.420(2)Å c=12.238(2)Å
α=79.38(2)° β=71.06(2)° γ=71.20(2)°
1-benzyloxy-4-nitrobenzene
C13H11NO3
Acta Crystallographica Section E (2007) 63, 10 o4087-o4087
a=14.0913(18)Å b=10.7640(14)Å c=7.6056(10)Å
α=90° β=100.349(2)° γ=90°
Sulfamethoxazole chloride
C10H12N3O3S,Cl
Acta Crystallographica Section E (2007) 63, 11 o4312-o4313
a=8.677(2)Å b=15.615(3)Å c=10.435(2)Å
α=90° β=111.29(2)° γ=90°
2,6-Diamino-5-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-ylmethyl)-4-oxopyrimidin-1-ium 3,5-dinitrobenzoate
C9H13N8O2,C7H3N2O6
Acta Crystallographica Section E (2007) 63, 11 o4408-o4409
a=7.365(2)Å b=19.788(3)Å c=13.658(2)Å
α=90° β=92.70(2)° γ=90°
2,4-diamino-6-phenyl-1,3,5-triazine--sorbic acid (1/1)
C9H9N5,C6H8O2
Acta Crystallographica Section E (2007) 63, 11 o4450-o4451
a=33.867(2)Å b=7.4289(3)Å c=12.2015(8)Å
α=90° β=94.241(2)° γ=90°
Pyrimethamine nicotinate
C12H14ClN4,C6H4NO2,H2O
Acta Crystallographica Section E (2007) 63, 11 o4452-o4452
a=6.570(2)Å b=16.055(3)Å c=9.480(2)Å
α=90° β=99.19(3)° γ=90°
2,6-Diaminopyrimidin-4(3H)-one--4-nitrobenzoic acid (1/1)
C4H6N4O,C7H5NO4
Acta Crystallographica Section E (2007) 63, 11 o4244-o4244
a=7.295(3)Å b=9.781(2)Å c=10.104(3)Å
α=102.27(3)° β=107.76(2)° γ=105.76(3)°
2-amino-4,6-dimethoxy pyrimidine phthalic acid
C6H9N3O2,C8H6O4
Acta Crystallographica Section E (2007) 63, 11 o4212-o4212
a=11.2175(3)Å b=7.3323(2)Å c=17.7651(4)Å
α=90° β=90.776(2)° γ=90°
2-amino-4,6-dimethoxy pyrimidinium salicylate
C6H10N3O2,C7H5O3
Acta Crystallographica Section E (2007) 63, 12 o4555-o4556
a=9.1071(3)Å b=14.7657(6)Å c=12.2829(6)Å
α=90° β=123.465(3)° γ=90°
2-amino-4,6-dimethyl pyrimidine terephthalic acid
C8H6O4,2(C6H9N3)
Acta Crystallographica Section E (2007) 63, 12 o4822-o4823
a=3.9689(2)Å b=15.1778(8)Å c=16.5995(8)Å
α=90° β=95.083(3)° γ=90°
2-amino-4,6-dimethoxy pyrimidine anthranilic acid
C6H9N3O2,C7H7NO2
Acta Crystallographica Section E (2008) 64, 1 o107-o108
a=7.2802(3)Å b=7.4095(2)Å c=25.8035(9)Å
α=83.636(2)° β=83.1620(10)° γ=82.373(2)°
2-Amino-4,6-dimethylpyrimidinium 3,5-dinitrobenzoate dihydrate
C6H10N3,C7H3N2O6,2H2O
Acta Crystallographica Section E (2008) 64, 2 o426-o426
a=7.1465(3)Å b=11.0215(5)Å c=11.1531(4)Å
α=99.473(3)° β=101.322(3)° γ=100.826(2)°
Pyrimethaminium 3,5-dinitrobenzoate
C12H14ClN4,C7H3N2O6
Acta Crystallographica Section E (2007) 63, 9 o3775-o3775
a=13.034(2)Å b=7.099(2)Å c=22.468(3)Å
α=90° β=97.11(3)° γ=90°
Trimethoprim 3,5-dinitrosalicylate
C14H19N4O3,C7H3N2O7
Acta Crystallographica Section E (2007) 63, 10 o4049-o4049
a=20.928(3)Å b=4.898(2)Å c=22.869(2)Å
α=90° β=90° γ=90°
Sulfamethoxazole cadmium(II) chloride monohydrate
2(C10H12N3O3S),CdCl42,H2O
Acta Crystallographica Section E (2008) 64, 1 m250-m251
a=15.088(2)Å b=35.028(3)Å c=5.562(3)Å
α=90° β=90° γ=90°
Pyrimethamine tetrafluoroborate
C12H14ClN4,BF4
Acta Crystallographica Section E (2007) 63, 6 o2966-o2966
a=8.3042(2)Å b=13.2529(4)Å c=13.7368(4)Å
α=90° β=97.326(2)° γ=90°
Ferron 4,4'-bipyridinium dihydrate
C10H9N21,C9H5INO4S1,2H2O
Acta Crystallographica Section C (2004) 60, 4 o284-o286
a=9.657(3)Å b=15.213(3)Å c=14.679(2)Å
α=90° β=106.01(3)° γ=90°
2-amino-4,6-dimethylpyrimidinium salicylate
C6H10N3,C7H5O3
Acta Crystallographica Section C (2006) 62, 10 o605-o607
a=11.039(2)Å b=13.995(3)Å c=17.371(3)Å
α=90° β=99.04(3)° γ=90°
2-amino-4,6-dimethoxypyrimidinium 4-hydroxybenzoate monohydrate
C6H10N3O2,C7H5O3,H2O
Acta Crystallographica Section C (2007) 63, 5 o295-o300
a=6.9710(2)Å b=10.9014(3)Å c=18.3749(6)Å
α=90° β=93.631(2)° γ=90°
2-amino-4,6-dimethoxypyrimidinium 6-carboxypyridine-2-carboxylate monohydrate
C6H10N3O2,C7H4NO4,H2O
Acta Crystallographica Section C (2007) 63, 5 o295-o300
a=6.8247(6)Å b=7.9273(5)Å c=14.4038(10)Å
α=82.558(5)° β=88.133(4)° γ=75.075(5)°
2-amino-4,6-dimethoxypyrimidinium hydrogen L-tartrate 2-amino-4,6-dimethoxypyrimidine
C6H10N3O2,C4H5O6,C6H9N3O2
Acta Crystallographica Section C (2007) 63, 5 o295-o300
a=7.3245(2)Å b=15.8349(6)Å c=8.9264(3)Å
α=90° β=105.251(2)° γ=90°
Pyrimethaminium(2+) nitrate
C12H15ClN42,2NO3
Acta Crystallographica Section C (2005) 61, 10 o586-o588
a=32.700(7)Å b=12.926(3)Å c=16.065(3)Å
α=90° β=104.73(3)° γ=90°
2-amino-4,6-dimethylpyrimidinium hydrogensulfate
C6H10N3,H1O4S1
Acta Crystallographica Section C (2005) 61, 2 o95-o97
a=7.0250(10)Å b=6.7240(10)Å c=20.200(4)Å
α=90.00° β=90.27(3)° γ=90.00°
Trimethoprim picolinate
C14H19N4O3,C6H4NO2
Acta Crystallographica Section C (2006) 62, 2 o107-o110
a=9.0642(3)Å b=10.2730(3)Å c=12.1188(4)Å
α=108.051(17)° β=98.741(2)° γ=107.517(2)°
2-amino-4,6-dimethylpyrimidinium picolinate hemihydrate
C6H10N3,C6H4NO2,0.5H2O
Acta Crystallographica Section C (2006) 62, 2 o107-o110
a=15.7666(4)Å b=8.79800(10)Å c=18.5038(4)Å
α=90° β=102.7400(10)° γ=90°